Table 4 Treatment modalities
Male | Female | Total | P- value | |
|---|---|---|---|---|
N = 102 | N = 66 | N = 168 | ||
Surgery | 89 (52.98) | 57 (33.93) | 146(86.90) | 0.87 |
Laparotomy | 69 (41.07) | 36 (21.43) | 105 (62.50) | 0.09 |
Laparoscopic | 3 (1.79) | 1 (0.60) | 4 (2.38) | 1.00 |
Endoscopic | 17 (10.12) | 20 (11.90) | 37 (22.02) | 0.04 |
TACE | 2 (1.19) | 1 (0.60) | 3 (1.79) | 1.00 |
Pharmacotherapy | ||||
Chemotherapy | 14 (8.33) | 4 (2.38) | 18 (10.71) | 0.12 |
Octreotide | 12 (7.14) | 12 (7.14) | 24 (14.29) | 0.25 |